EPHX2 and early-onset autosomal dominant Alzheimer disease: Studies have implicated soluble epoxide hydrolase (sEH) in many disorders of the central nervous system, including Parkinson’s disease, white matter hyperintensities, vascular cognitive decline/impairment, and Alzheimer’s disease [22,23,24,25,26].